(Q45855568)

English

TNFerade Biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

TNFerade Biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

Ralph Weichselbaum

7

object named as

Ralph Weichselbaum

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

author name string

Henrik Rasmussen

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

Camilla Rasmussen

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

Maria Lempicki

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

Rebecca Durham

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

Douglas Brough

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

C Richter King

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

11

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

951-957

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

A p75 tumor necrosis factor receptor-specific mutant of murine tumor necrosis factor alpha expressed from an adenovirus vector induces an antitumor response with reduced toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Adenovirus-mediated TNF-alpha gene transfer induces significant tumor regression in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Tumor necrosis factor alpha selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

21 January 2018

Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNF alpha)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700518

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700518

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12386834

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45855568&oldid=2207386724"